LSB — LakeShore Biopharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- $23.28m
- $66.85m
- CNY573.42m
Annual cashflow statement for LakeShore Biopharma Co, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -192 | -106 | -145 | -433 |
| Depreciation | ||||
| Amortisation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 86.5 | 21.3 | 17.9 | 164 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -187 | -125 | -92.7 | -45.8 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -247 | -174 | -182 | -295 |
| Capital Expenditures | -105 | -299 | -57 | -44.3 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.645 | 0.008 | 0.068 | 0 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | -104 | -299 | -57 | -44.3 |
| Financing Cash Flow Items | — | — | 217 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 739 | 365 | 317 | 205 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 388 | -119 | 99.3 | -124 |